Newshot

Nature: Diabetic Rats Successfully Restore Normal Blood Glucose! Using Electrical Stimulation of the Vagus Nerve to Control Blood Sugar

AI summary

Using glucose to generate electricity to control blood sugar.

Translation(model translation, not the source's own text)

Nature: Diabetic Rats Successfully Restore Normal Blood Glucose! Controlling Glucose with Electrical Stimulation of the Vagus Nerve

No insulin injections needed—diabetes can be controlled by using glucose in the body to generate electricity that stimulates nerves.

In the latest Nature study, the National University of Singapore and Nanjing University of Posts and Telecommunications built an implantable device that successfully restored normal blood glucose in diabetic rats.

According to the experimental results, blood glucose in type 2 diabetic rats dropped to near the level of healthy rats just two weeks after device implantation; type 1 diabetic rats restored normal blood glucose control after eight weeks of treatment, and researchers even observed proliferation and recovery of pancreatic islet β cells.

The basic principle of this device is to use glucose to generate electricity, then through electrical stimulation of the vagus nerve, mobilize the body's pre-existing neuroimmune regulatory mechanisms, and at the same time automatically decide when to start and stop stimulation based on changes in blood glucose.

The research team named this system NeuroAxis (artificial neuroimmune axis).

Why can stimulating the vagus nerve control glucose?

We know that insulin is the key hormone for regulating blood glucose in the human body. It is secreted by pancreatic islet β cells and can help cells in the body absorb and utilize glucose, thereby lowering blood glucose.

But this regulatory mechanism goes wrong in diabetic patients, and blood glucose needs to be controlled by supplementing insulin, promoting insulin secretion, or improving insulin sensitivity.

Among these, type 1 diabetes is mainly caused by the immune system mistakenly attacking pancreatic islet β cells, resulting in the body being unable to secrete enough insulin.

Type 2 diabetes mainly involves insulin resistance and the gradual decline of pancreatic islet β cell function. Even if insulin is present in the body, it cannot fully exert its effect.

But in fact, the pancreas is not the only part of the human body responsible for regulating blood glucose. The brain, liver, gastrointestinal tract, and even the immune system all participate in the blood glucose regulation process.

And one of the important pathways connecting these organs is the vagus nerve.

The vagus nerve is an important autonomic nerve in the human body, extending downward from the brainstem and widely connecting internal organs such as the heart and gastrointestinal tract. Among its fibers, afferent nerves are responsible for conveying the body's physiological state to the brain, while efferent nerves participate in transmitting central regulatory signals to peripheral organs.

Both of these neural pathways are related to blood glucose regulation. How do they regulate it?

First, the neural pathway. When we eat, the gastrointestinal tract produces a series of physiological changes and transmits information to the brain through signaling pathways including the vagus nerve. After receiving these signals, the brain participates in regulating appetite, satiety, and energy intake.

This study also found that stimulating the vagus nerve can activate regions in the brain involved in feeding regulation, thereby affecting rats' appetite and energy intake, and thus participating in body weight and metabolic regulation.

But eating less is not enough to properly regulate blood glucose. This involves another important function of the vagus nerve: regulating the immune system.

The researchers focused on a mechanism called the "cholinergic anti-inflammatory pathway." This mechanism is important for diabetes because type 2 diabetes is often accompanied by long-term low-grade chronic inflammation.

Especially in obesity-related type 2 diabetes, immune cells in adipose tissue may continuously release pro-inflammatory factors such as tumor necrosis factor (TNF) and interleukin-1β (IL-1β). These inflammatory signals interfere with the normal action of insulin, aggravate insulin resistance, and make it increasingly difficult for the body to effectively utilize glucose.

Stimulating the efferent pathway of the vagus nerve is expected to inhibit the release of pro-inflammatory factors, reduce chronic inflammation, and improve insulin resistance.

So, can diabetes be treated by artificially stimulating the vagus nerve to actively regulate the body's immune and metabolic activities?

This idea has been put into practice before.

But a relatively major problem is that traditional implantable vagus nerve stimulators require battery power and mostly adopt preset stimulation protocols.

But for a disease like diabetes with continuously fluctuating blood glucose, ideally the device should be able to determine on its own when to stimulate and when to stop.

Therefore, this study proposed "letting glucose itself power the device and at the same time determine when to start treatment."

To this end, they designed the device "NeuroAxis." This small device mainly has three parts: a glucose fuel cell responsible for sensing and power supply, a flexible control circuit responsible for decision-making, and a deformable neural electrode responsible for stimulation.

△Schematic diagram of the structure and composition of the NeuroAxis device | Image source: the paper, translated and redrawn

Among them, the researchers used the principle that a glucose fuel cell senses glucose concentration in the body through voltage changes to design an automatic control program based on voltage thresholds, responsible for deciding "when to stimulate."

The system collects the fuel cell's output voltage every 30 minutes. In rat experiments, the researchers set a glucose concentration of 11.1 mmol/L as the hyperglycemia threshold, corresponding to about 0.6 V.

If the voltage exceeds this threshold five consecutive times, the system automatically outputs biphasic electrical pulses to the vagus nerve lasting 3 minutes.

This is also to avoid unnecessary stimulation triggered by transient blood glucose fluctuations after eating.

When blood glucose returns to normal, the device no longer triggers stimulation and returns to monitoring and standby mode.

The final step of delivering electrical signals to the vagus nerve also involves considerable technical difficulty, because the tissue environment around the vagus nerve continuously deforms with breathing, swallowing, and body activity, and the esophagus and surrounding tissues are constantly changing shape.

To this end, the research team developed a deformable flexible electrode with self-repairing capability. It is composed of conductive polymers and elastic materials and can transform from a flat thin-film form into a ring-shaped structure that conforms to the vagus nerve near the rat esophagus.

△How the flexible electrode conforms to the esophagus | Image source: the paper, translated and redrawn

At this point, the entire NeuroAxis system forms an autonomous closed loop.

How far is it from actually treating human diabetes?

The researchers first conducted a six-week experiment on type 2 diabetic rats. After only two weeks of treatment, the rats' blood glucose had dropped to a level close to that of healthy rats.

Not only did blood glucose fall, but these rats' food intake and body weight also continued to decline, and body fat accumulation was significantly reduced.

Moreover, as blood glucose returned to normal, the device no longer triggered nerve stimulation. Even so, the improvement in blood glucose was maintained until the end of the six-week experiment.

In other words, the effect of nerve stimulation may not be temporary; it can bring sustained therapeutic effects by regulating immune and metabolic status.

△Changes in blood glucose of type 2 diabetic rats after NeuroAxis treatment | Image source: the paper, translated and redrawn

The researchers then conducted an eight-week experiment on type 1 diabetes model rats. The results showed that the rats' blood glucose and glycated hemoglobin (HbA1c) levels continued to decline, while blood insulin levels gradually increased.

By the eighth week, these rats had restored normal blood glucose control.

The research team examined the rats' pancreatic tissue and observed more proliferating pancreatic islet β cells in pancreatic sections!

That is, nerve stimulation not only improved the rats' blood glucose levels but may also have helped them restore their own ability to secrete insulin.

However, the biological differences between rats and humans cannot be ignored.

The proliferation capacity of adult human pancreatic islet β cells differs from that of rats. For patients who have had the disease for many years, there may no longer be enough functional β cells in the body to recover.

Moreover, the core problem of human type 1 diabetes is that the autoimmune system continuously attacks pancreatic islet β cells.

Even if nerve stimulation successfully promotes β cell proliferation, it is hard to say that these cells will not be destroyed again later.

In addition, whether this device can operate safely in the human body over the long term is also a question.

Although the researchers did not observe obvious behavioral abnormalities, local inflammation, or abnormalities in important blood biochemical indicators in the rat implantation experiments.

However, in long-term immersion experiments simulating the physiological environment, after the fuel cell operated for 90 days, its power density had dropped to 64.5% of the initial level.

For an implantable device that may need to be used for years or even longer, this is also an engineering problem to be solved later.

One More Thing

In fact, scientists' exploration of neural glucose control has lasted for nearly 20 years.

As early as 2008, a research team at Tohoku University in Japan found in Science that neural signals can promote pancreatic islet β cell proliferation; since then, scientists have successively verified the effects of vagus nerve stimulation on insulin secretion and blood glucose regulation.

But the core innovation this time lies in letting glucose serve simultaneously as an energy source and a metabolic sensing signal, building a closed-loop neural stimulation system that requires no battery and can regulate autonomously, and also verifying the possibility of restoring blood glucose homeostasis through neuroimmune regulation.

Although there is still a long way to go before it is truly used in humans, we still hope that one day diabetic patients will no longer need to bear the pain of insulin injections.

Paper: https://www.nature.com/articles/s41586-026-11251-7

  • He never did a day of R&D, yet retired at 50 as a Huawei board member 2026-11-16
  • Gemini's new model Neon is about to launch, netizens: iterating through the periodic table? 2026-11-18
  • Programmers collectively obsessed with paper airplanes! Longest hang time 31.2 seconds 2026-11-14
  • Tesla and SpaceX may merge as soon as next month 2026-11-13

Related Reading

The "demon" predicted by physicists 67 years ago appears in Nature: accidentally discovered in a "fake" high-temperature superconductor

"Just because we simply tried different things."

Nature: Diabetic Rats Successfully Restore Normal Blood Sugar! Electrical Stimulation of the Vagus Nerve Controls Blood Sugar

Nature Cover Paper Idea Stolen? UC San Diego's Fu Xiangdong Reports CAS Researcher for Plagiarism

Just released less than 10 days ago, and it's already been found to be plagiarized?

Hope Out of Nowhere on Baldness! New Nature Study: Pluripotent Stem Cells Can Form Nearly Complete Skin Structures, Successfully Growing Hair After Transplantation in Mice

Table Processing Tool Makes It onto Nature! Out of the Box, Decoding Any Table in an Average of 2.8s

Nature: AI Reborn in 1900, This Life Beats Einstein to Propose the Light Quantum

Is This What You Looked Like at 21 Days? Cambridge PhD Researcher Studies "Artificial Embryos," Lands 2 Nature Papers

First simulation of the "gastrulation" process

The translation is machine-generated and individual terms may be off. Nothing is rewritten or cut; the original is authoritative.

Published by 量子位
This site only summarises and aggregates; copyright stays with the original author. Headlines and summaries follow the source — where they differ, the original wins.
Read the original ↗